CLINICAL RESEARCH POLICIES
As a Consortium Cancer Center that is comprised of four institutions, we are continuously challenged to ensure that all the cancer trials at our center are conducted with the highest possible standards for safety and scientific integrity. Ensuring the safety and integrity of clinical trials is not only essential to our research, but is also an integral part of meeting expectations for our NCI-designated Comprehensive Cancer Center. One of these expectations is that our Center has a uniform set of policies that govern all cancer-related clinical research.
The Clinical Research Oversight Committee (CROC) is charged with approving and ensuring adherence to Consortium policies and procedures as well as overseeing compliance with applicable regulations and guidelines. The committee is chaired by the Fred Hutchinson Cancer Research Center Deputy Director, and has representation from all the Consortium partner institutions.